Introduction
============

Hepatic ischemia/reperfusion (I/R), or the interruption of blood flow to the liver followed by subsequent reperfusion, causes an acute inflammatory response that causes cellular damage and organ dysfunction and contributes to major complications after liver transplantation or partial hepatectomy [@B1], [@B2]. The mechanism of hepatic I/R injury is complex and is controlled by multiple cytokines. Jaeschke *et al.* verified two obvious phases during acute liver injury after hepatic I/R [@B3], [@B4] and showed that Kupffer cells (KCs), the resident macrophages of the liver, are extremely important to the pathophysiological process of I/R-induced acute liver injury [@B5]-[@B7]. Once KCs are activated, pro-inflammatory cytokines including tumour necrosis factor alpha (TNF-α) and interleukin1β (IL-1β) as well as reactive oxygen species (ROS), which initiate oxidative stress, are released, subsequently promoting neutrophil infiltration into hepatic microcirculation and aggravating liver cell injury [@B8]-[@B10].

Currently, several pharmacological and mechanical methods have been identified that attenuate liver I/R in animal studies. For instance, melatonin, which is a molecule with notable antioxidant and anti-inflammatory properties, protects against hepatic I/R injury via Jun N-terminal kinase (JNK) pathway inhibition [@B11]. As a mechanical method, ischemic postconditioning (IPO), which is defined as a short series of repetitive cycles of brief reperfusion and re-occlusion applied at the onset of reperfusion after a prolonged ischemic insult, has been used to attenuate organ I/R injury in the heart [@B12], [@B13], bowel [@B14], kidney [@B15], [@B16], brain [@B17] and liver [@B18], [@B19]. Although IPO has been shown to provide protective effects against hepatic I/R injury, little is known about the underlying biological pathophysiology, which encouraged us to investigate the molecular mechanisms and pathways.

Recently, the rapid development of next-generation RNA-Seq analysis has promoted the exploration of complex diseases progression and the identification of biomarkers. For example, the RNA- Seq technique could provide high-resolution sequence information about alcoholic liver disease (ALD), through which Sun identified some new targets for the early diagnosis and therapeutic management of ALD [@B20]. In a previous study, Arai *et al.* revealed the mechanism and pathophysiology of mouse liver regeneration through gene expression profiling [@B21]. Altered gene expression in IPO to attenuate liver I/R injury is tightly associated with the pathophysiology and understanding IPO requires a detailed study of the transcriptomic changes that underpin this process. However, the gene expression profile during IPO attenuating hepatic I/R injury was not reported in the previous research. In this study, we explored gene expression profiles using next-generation RNA-Seq, and subsequent bioinformatics analyses were performed to assess the differentially expressed genes (DEGs) function and pathways relevant to hepatic I/R injury and IPO.

Methods and materials
=====================

Ethics Approval
---------------

This research protocol was approved by the Committee on the Ethics of Animal Experiments of the Third Xiangya Hospital and was conducted according to the Guidance for the Care and Use of Laboratory Animals of the National Institute of Health (No. LLSC (LA) 2016-030).

Animal model
------------

A total of 20 male SPF mice (9-week-old, C57BL/6) were provided by Hunan SLAC Laboratory Animals (Hunan, China). All of the mice were housed in a standard room with ad libitum water, rodent food and a 12/12 h light/dark cycle for two weeks. After an acclimatization period, 20 mice were randomly divided into three groups: the normal (N) group (n = 6), the I/R group (n = 7, subjected to 70% hepatic I/R) and the I/R+IPO group (n = 7, applying IPO to mice with I/R injury). Two mice were excluded because of death during procedure, and each of them was from the I/R and IPO group. Finally,18 mice were included for further research and the final number per group was six. The model for partial (70%) hepatic I/R was used in accordance with previous reports [@B22], [@B23]. All mice were anaesthetized with intraperitoneal injections of sodium pentobarbital (10 mg/kg). Group N received a laparotomy without vessel blockage and the I/R group had liver ischemia induced for 1 h and then reperfusion for 4 h. The IPO group received occlusion of the porta hepatis for 1 h and was then treated with three consecutive 5-sec cycles of reperfusion followed by persistent reperfusion for 4 h. All of the mice were sacrificed, and samples (liver and blood) were collected for further analysis.

Serum enzyme and inflammation factor analyses
---------------------------------------------

To assess the hepatocyte injury severity, we measured the serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels using a HITACHI 7600 Automatic Analyzer (Japan, U/L) and TNF-α and IL-1β using an Abcam ELISA kit (USA, pg/ml).

Total RNA isolation, RNA-seq library preparation and next-generation RNA-Seq
----------------------------------------------------------------------------

Total RNA was extracted from nine frozen mouse liver tissues (three randomly selected samples from each group) using TRIzol (Invitrogen, USA) according to the manufacturer\'s instructions. After quality inspection and mRNA enrichment, we used KAPA Stranded RNA-Seq Library Prep Kit (Illumina, USA) for RNA-seq library preparation, which included RNA fragmentation, random hexamer-primed first strand cDNA synthesis, dUTP-based second strand cDNA synthesis, end-repairing, A-tailing, adaptor ligation and library PCR amplification. Finally, the prepared RNA-seq libraries were qualified using an Agilent 2100 Bioanalyzer (Illumina, USA) and quantified by the qPCR absolute quantification method. Next-generation RNA-Seq was performed using the Illumina HiSeq 4000 (Illumina, USA) according to the manufacturer\'s instructions for 150 cycles.

Bioinformatics analysis
-----------------------

When the data were extracted, subsequent data processing was performed to use the R software Ballgown package. DEGs between the two groups were identified using fold change (FC) and*p*-values (FC ≥ 1.5 and*p*-value \< 0.05). Scatter plot analysis was conducted to depict the mRNA expression distribution. Hierarchical clustering was performed to show distinguishable mRNA expression profiles among the samples. The volcano graph was created to visualize significantly dysregulated mRNAs. GO analysis was used to investigate three functionality domains: Biological Process (BP), Cellular Component (CC) and Molecular Function (MF)[@B24]. Pathway analysis was performed to functionally analyse and map genes to KEGG pathways. The*p*-value denotes the significance of the GO and KEGG pathway correlated with the various conditions (*p* \< 0.05). The interaction of DEGs with our previous key circRNAs was determined by Coding & Noncoding Co-expression (CNC) analysis, and the CNC network was delineated by Cytoscape according to partial correlation coefficient (PCC) and *p*-value (PCC ≥ 0.9 and *p* \< 0.05). A PPI network constructed to determine interactions of these DEGs by STRING analysis.

Validation of selected genes by qRT-PCR
---------------------------------------

Further qRT-PCR validation was performed with a ViiA 7 real-time PCR system (Applied Biosystems, USA) in triplicate for each sample. All of the primers were designed and synthesized by Kangchen Bio-tech (Shanghai, China). mRNA expression was defined as the threshold cycle (Ct), and GAPDH was amplified as the internal control. The relative amounts of selected mRNAs were calculated using the double-standard curve method.

Statistical analysis
--------------------

All the results were expressed as the mean ± standard deviation. The data were statistically analysed and visualized with GraphPad Prism 5.0. A *p-*value less than 0.05 was used to indicate statistical significance.

Results
=======

IPO attenuated liver I/R
------------------------

The effect of hepatic I/R injury and IPO was evaluated be assessing the serum levels of ALT, AST, IL-1β and TNF-α. The ALT, AST, IL-1 β and TNF-α serum levels were significantly increased in the I/R group compared with those in the N group. However, these values decreased significantly in the IPO group compared with those in the I/R group (Figure [1](#F1){ref-type="fig"}), indicating that IPO attenuated I/R injury successfully.

mRNA expression patterns during IPO protection against hepatic I/R injury via next-generation RNA-Seq analysis
--------------------------------------------------------------------------------------------------------------

Next-generation RNA-Seq showed that 2,416 of 22,249 genes were differentially expressed overall (*p* \< 0.05 and FC ≥ 1.5). Of these, we identified that 320 and 567 genes were up-regulated and down-regulated, respectively, between the N and I/R group. Additionally, 853 and 676 genes were up-regulated and down-regulated, respectively, in the IPO group compared with their expression in the I/R group. Scatter plot graph analysis was conducted to depict the gene expression distribution (Figure [2](#F2){ref-type="fig"}A). Hierarchical clustering analysis evaluated these 2416 significantly expressed genes, which were indicated by *p* \< 0.05 and an FC ≥ 1.5 between the N, I/R and IPO groups (Figure [2](#F2){ref-type="fig"}B). Each column represents the expression pattern of one sample, and high and low expression levels are indicated by the "red" and "green" lines, respectively. The volcano graph was created to visualize significant DEGs (Figure [2](#F2){ref-type="fig"}C). CNC analysis integrated these DEGs and our previously verified six circRNAs with the hepatic I/R injury and IPO data. Additionally, 380 DEGs had roles establishing the regulation network, as depicted in Figure [3](#F3){ref-type="fig"}.

GO and KEGG pathway analysis of differentially expressed genes
--------------------------------------------------------------

The top 10 GO terms from the BP, CC, and MF domains in the compared groups are ranked according to enrichment score and by*p*-value (Figure [4](#F4){ref-type="fig"}).

In the BP domain, the most meaningful enriched GO terms were related to nucleic acid and cellular metabolic processes and included RNA metabolic process (GO:0016070), Nucleic acid metabolic process (GO:0090304), Gene expression (GO:0010467), Cellular macromolecule metabolic process (GO:0044260) and Cellular metabolic process (GO:0044237).

The most enriched GO CC terms primarily focused on the cell, such as Organelle (GO:0043226), Membrane-bounded organelle (GO:0043227), Intracellular organelle (GO:0043229), Cytoplasm (GO:0005737) and Nucleus (GO:0005634).

As for MF terms, nucleic acid and protein binding were very important in the GO terms ranked by enrichment score. Represented terms were Nucleic acid binding (GO:0003676), DNA binding (GO:0003677), RNA binding (GO:0003723), Transcription factor binding (GO:0008134), Transcription factor activity and sequence-specific DNA binding (GO:0003700) and Protein binding (GO:0005515).

Moreover, KEGG pathway analysis was performed, and pathways were selected and ranked by *p*-value. Overall, 125 pathways were connected to in hepatic I/R injury and IPO. The top 10 pathways in the compared groups (N vs. I/R and I/R vs. I/R+IPO) were listed according to enrichment score and were ranked by*p*-value (Figure [5](#F5){ref-type="fig"}). Identical pathways in both sets were the MAPK signalling pathway, the IL-17 signalling pathway, regulating pluripotency of stem cells, and the insulin resistance pathway.

Validation of selected DEGs by qRT-PCR
--------------------------------------

Twelve DEGs were selected based on a combination of *p*-value, FC, PCC and Fragments per Kilobase of transcript per million mapped reads (FPKM) (Table [1](#T1){ref-type="table"}). All of the primers were designed and synthesized by Kangchen Bio-tech (Table [2](#T2){ref-type="table"}). The results confirmed that consistent with the RNA-Seq results, 11 genes were significantly amplified by qRT-PCR including Cyr61, Atf3, Nr4a1, Gdf15, Osgin1, Egr1, Epha2, Dusp1, Dusp6, Gadd45a and Gadd45b (Figure [6](#F6){ref-type="fig"}).

To determine how these 11 DEGs interact with each other, we identified potential PPI network for these DEGs (Figure [7](#F7){ref-type="fig"}). Signal-net analysis integrated these 11 genes using STRING analysis and 61 nodes were involved in the establishment of the gene regulation network, with 636 edges. From the PPI network, we found that MAPK gene family made a significant contribution to the interactions of these DEGs, which indicated the importance of MAPK pathway.

Discussion
==========

We used next-generation RNA-Seq to explore gene expression profiling in regard to hepatic I/R and IPO. In this study, we identified 2416 DEGs that have potential to be novel regulators and might, at least in part, elucidate the pathophysiological mechanism of IPO in attenuating hepatic I/R injury. Through the use of bioinformatics analysis, we found that the most enriched BP and MF terms for DEGs were almost all related to intracellular nucleic acid and protein metabolic and binding processes, indicating that hepatocyte necrosis and proliferation play a crucial role in hepatic I/R injury and IPO-induced protection. Our findings agree with a previous report stating that cell necrosis and apoptosis caused by damaged ATP biosynthesis contributes substantially to inflammation in the hepatic reperfusion period [@B25].

In this study, we found the same top 10 significantly enriched pathways between N vs. I/R and I/R vs. I/R+IPO, which were the MAPK pathway, the IL-17 pathway, regulating pluripotency of stem cells, and insulin resistance pathway. The MAPK signalling pathway primarily consists of an extracellular signal‑regulated kinase that regulates numerous cellular activities, including proliferation, differentiation, survival, death and transformation. Signalling activated upon hepatic I/R injury includes members of the MAPK family [@B26] and, as mentioned in a recent study, propylene glycol alginate sodium sulphate pre-conditioning, which attenuated hepatic I/R injury by focusing on the MAPK pathway [@B27]. IL-17 is a pro-inflammatory cytokine with a key role recruiting neutrophils and macrophages to sites of inflammation, subsequently causing damage after hepatic I/R injury [@B28]. Furthermore, Patrizia *et al.* demonstrated that interferon regulatory factor 3 deficiency enhances hepatic I/R injury by mediating the IL-17 pathway [@B29]. Pluripotent stem cells (PSCs), which are induced from mesenchymal stem cells (MSCs), have been utilized for basic research because of their high proliferation rate and engraftment capacity [@B30]. Several reports investigated the pivotal role of PSCs on I/R injury. For instance, glutathione peroxidase 3 delivered in human-induced PSCs (hiPSCs) attenuated hepatic I/R injury by inhibiting hepatic senescence and extracellular vesicles released from MSCs, which protect against murine renal and hepatic I/R injury [@B31]-[@B33]. Insulin is an important hormone that reduces plasma glucose *in vivo* and is regulated by insulin signalling. Although a previous report indicated that hepatic I/R injury regulates insulin signalling during the early reperfusion phase, the mechanism of insulin resistance in hepatic I/R injury remains unclear. The above results agree with previous evidence and reported mechanisms, highlighting the ability and accuracy of RNA-Seq analysis. In the meantime, we suggest that IPO might protect against hepatic I/R injury by regulating the four predicted pathways.

Data from selected DEGs verification experiments revealed 11 significantly changed genes following qRT-PCR amplification. The expression trend for the 11 qRT-PCR genes was consistent with the RNA-Seq data. Cyr61, which is a gene with one of the largest fold changes in this study, belongs to the CNN protein family and regulates complex cellular activities such as cell adhesion, proliferation and apoptosis [@B34]. Bian *et al.* reported that Cyr61 expression in hepatocytes was involved in the hepatic pro-inflammatory response and macrophage infiltration in murine non-alcoholic fatty liver disease [@B35], which agrees with the results of this study. Furthermore, Atf3, which is a member of the ATF/cyclic AMP-responsive element binding protein transcription factor family that represses inflammatory gene expression in multiple diseases [@B36], was also significantly up-regulated. Several previous reports demonstrated that I/R can significantly increase Atf3 expression during the reperfusion phase in the kidney, heart and brain [@B37]-[@B39]. As far as we know, regarding the potential mechanisms involved in the IPO, several studies have postulated that IPO decreases the burst production of pro-inflammatory mediators [@B23], modulates the hepatocytes apoptotic cascade [@B10], and improves liver regeneration [@B40], which showed good agreement with our data. Taken together, we suggest Cyr61 and Atf3 may serve a vital role in the development of IPO attenuating hepatic I/R injury.

Furthermore, six amplified DEGs (Dusp1/6, Gadd45a/b, Egr1 and Epha2) were significantly enriched in the predicted MAPK signalling pathway, emphasizing the importance of this pathway in the hepatic I/R and IPO process. Dusp 1/6 is a member of the Dusp protein family, which dephosphorylates the threonine/ serine and tyrosine residues of their substrates [@B41]. Tongda Xu revealed that in myocardial I/R injury, inhibition of Dusp2- mediated c-JNK dephosphorylation and activation of Dusp4/16-mediated extracellular regulated protein kinases1/2 (ERK1/2) phosphorylation exerted an anti-apoptotic role [@B42]. Furthermore, Gadd45b and Egr1 appeared to be pivotal factors preventing apoptosis and autophagy during cerebral I/R injury [@B43], [@B44]. And targeting Epha2 receptors might be a novel anticancer strategy because of the critical role Epha signalling plays in tumour growth and metastasis [@B45]. The functions of six DEGs were mainly associated with apoptosis and autophagy, which was in line with MAPK pathway\'s role. At the same time, PPI network indicated that MAPK pathway played a significant part in these DEGs interactions. Several studies also have reported that IPO inhibits apoptosis after renal and liver I/R injury [@B16], [@B46]. Our data and previous evidences have suggested that these DEGs and MAPK pathway makes a contribution to IPO attenuating liver I/R injury. For other amplified DEGs, Chao *et al.* reported that Nr4a1 deletion altered systemic glucose metabolism and caused insulin resistance after deletion in mice [@B47]. The main connection of Gdf15 in liver disease has been with non-alcoholic steatohepatitis and hepatic fibrosis [@B48], [@B49]. In reviewing the literature, no evidence was discovered associating liver disease with Osgin1 or Lpin2 expression. However, the potential function and role of these DEGs in the pathophysiology of hepatic I/R injury and IPO require further exploration.

Conclusion
==========

To the best of our knowledge, this study is the first to explore gene expression profiling with regard to hepatic I/R and IPO using next-generation RNA-Seq. We suggested a few progression-related genes and pathways, such as Cyr61, Atf3, MAPK pathway and IL-17 pathway and so on, providing some clues for future experimental research. Further validations, particularly in human tissues, may provide more comprehensive understanding of the underlying biological pathophysiology surrounding ischemic postconditioning attenuating mouse liver I/R injury.
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![**Effect of hepatic I/R injury and IPO on serum aminotransferase levels and pro-inflammatory cytokines**. (**A**) Serum ALT and AST levels were detected by Automatic Analyzer during the I/R and IPO process. (**B** and **C**) The pro-inflammatory cytokines (IL-1β and TNF-α) were measured by ELISA kit. (n = 6 per group, \**p* \< 0.05, \*\**p* \< 0.01)](ijmsv16p0343g001){#F1}

![**Bioinformatics analysis of mRNA expression patterns during IPO and hepatic I/R injury by Next-generation RNA-Seq. A.** Scatter plot graph analysis was conducted to exhibit all the mRNA expression distribution. The dashed lines represent the default significant fold change (1.5) in the scatter plot analysis. **B.** Hierarchical clustering was used to evaluate the 2416 DEGs when comparing with each of normal, I/R and IPO group samples. One sample expression pattern was represented by each column and high and low expression was indicated by the "red" and "green" line, respectively.**C**. The volcano graph was performed to show significantly DEGs in a visible way and the vertical green lines correspond to 1.5-fold up- and down-regulation and the horizontal line represents the *p*-value (0.05)](ijmsv16p0343g002){#F2}

![**The CNC network analysis.** The network consists of 6 circRNAs (red) and 380 mRNAs (blue)](ijmsv16p0343g003){#F3}

![GO analysis of DEGs with top 10 Enrichment score under the theme of BP, CC and MF in N vs. I /R (A) and I/R vs. IPO (B) group](ijmsv16p0343g004){#F4}

![KEGG pathway analysis of N vs. I/R (A) and I/R vs. IPO (B) group with top 10 Enrichment score](ijmsv16p0343g005){#F5}

![**Validation of selected DEGs by qRT-PCR.** 12 DEGs were validated using qRT-PCR among 3 groups. And 11 of them were significantly amplified and consistent with the RNA-Sequencing results. \**p* \< 0.05](ijmsv16p0343g006){#F6}

![**Protein-protein interaction network of these 11 DEGs.** Nodes represented genes. Purple lines represented experimental evidence; yellow lines represented text-mining evidence; light lines represented database evidence; The red dashed frame labelled the MAPK gene family.](ijmsv16p0343g007){#F7}

###### 

12 DEGs were screened for validation by qRT-PCR.

  Gene Name   FC^a^   *p*-value   N_FPKM^b^   I/R_FPKM   IPO_FPKM   PCC^c^
  ----------- ------- ----------- ----------- ---------- ---------- --------
  Cyr61       23.8    0.0003      1.4         6          1.9        0.9524
  Atf3        22.1    0.0037      2.6         7.1        2.3        0.9454
  Nr4a1       8.7     0.0001      1.4         4.5        1.3        0.916
  Gdf15       8.5     0.0076      4           7.1        4.9        0.9253
  Osgin1      7.7     0.0256      3.7         6.6        3.2        0.9132
  Dusp6       5.2     0.0204      3.4         5.8        3.7        0.9368
  Gadd45b     5.2     0.0015      4.2         6.5        4.1        0.9634
  Dusp1       5.2     0.0048      4.5         6.9        4.6        0.9421
  Egr1        4.5     0.0285      4.2         6.4        3.3        0.9077
  Gadd45a     4.3     0.0181      3.5         5.6        3          0.9304
  Lpin2       3.3     0.0136      4.2         5.9        4.4        0.9178
  Epha2       2.7     0.0194      3           4.4        2.5        0.9393

^a^FC: Fold change. ^b^Group FPKM: Fragments per Kilobase of transcript per million mapped reads. ^c^PCC: partial correlation coefficient of CNC

###### 

The primers sequence used in this study

  ----------------------------------------------------------------------
  Gene name   Primer                               product length (bp)
  ----------- ------------------------------------ ---------------------
  GAPDH       F:5\' CACTGAGCAAGAGAGGCCCTAT 3\'\    144
              R:5\' GCAGCGAACTTTATTGATGGTATT 3\'   

  Cyr61       F:5\'CGAGTTACCAATGACAACCCAG 3\'\     223
              R :5\' TGCAGCACCGGCCATCTA 3\'        

  Atf3        F:5\' GGCGGCGAGAAAGAAATA 3\'\        206
              R :5\' ATTCTGAGCCCGGACGAT 3\'        

  Nr4a1       F:5\' TACCAATCTTCTCACTTCCCTC 3\'\    180
              R :5\' GCCCACTTTCGGATAACG 3\'        

  Gdf15       F:5\' AGAACCAAGTCCTGACCCAG 3\'\      51
              R:5\'AATCTCACCTCTGGACTGAGTAT 3\'     

  Osgin1      F:5\' GCAGAGGTCTCCGCAACA 3\'\        55
              R :5\' CGGTAGTAGTGGGCGATGT 3\'       

  Egr1        F:5\' GAGCGAACAACCCTATGAG 3\'\       102
              R :5\' GTCGTTTGGCTGGGATAA 3\'        

  Lpin2       F:5\' ACAGGACAATAGGAAGGAGGAG 3\'\    220
              R :5\' AGGGTAGGTGGTTTCTAATGG 3\'     

  Epha2       F:5\' AGGGAGAAGGATGGTGAGTT 3\'\      184
              R :5\' CTTCCAGCACACGCGAC 3\'         

  Dusp6       F:5\' CCCAATCTGTTTGAGAATGCG 3\'\     179
              R :5\' ACGGTGACAGAGCGGCTGA 3\'       

  Dusp1       F:5\' GCAGCAAACAGTCCACCC 3\'\        167
              R :5\' CCGAGAAGCGTGATAGGC 3\'        

  Gadd45b     F:5\' ACCCTGATCCAGTCGTTCT 3\'\       232
              R :5\' GGACCCATTGGTTATTGC 3\'        

  Gadd45a     F:5\' TGTGCTGGTGACGAACCC 3\'\        99
              R :5\' ACCCACTGATCCATGTAGCG 3\'      
  ----------------------------------------------------------------------
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